• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Correction to: Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.对《乳腺癌生物标志物：西班牙医学肿瘤学会和西班牙病理学会的共识声明》的勘误
Clin Transl Oncol. 2018 Aug;20(8):1093-1095. doi: 10.1007/s12094-018-1909-1.
2
Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.乳腺癌的生物标志物：西班牙肿瘤内科学会和西班牙病理学会的共识声明。
Clin Transl Oncol. 2018 Jul;20(7):815-826. doi: 10.1007/s12094-017-1800-5. Epub 2017 Dec 22.
3
[Consensus statement on biomarkers in breast cancer by the Spanish Society of Pathology and the Spanish Society of Medical Oncology].西班牙病理学会和西班牙医学肿瘤学会关于乳腺癌生物标志物的共识声明
Rev Esp Patol. 2018 Apr-Jun;51(2):97-109. doi: 10.1016/j.patol.2017.12.002. Epub 2018 Mar 14.
4
Biomarkers in breast cancer 2024: an updated consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.乳腺癌 2024 年的生物标志物：西班牙肿瘤内科学会和西班牙病理学会的最新共识声明。
Clin Transl Oncol. 2024 Dec;26(12):2935-2951. doi: 10.1007/s12094-024-03541-1. Epub 2024 Jun 13.
5
Correction to: Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.更正：肿瘤学中的液体活检：西班牙病理学学会和西班牙医学肿瘤学学会的共识声明。
Clin Transl Oncol. 2020 Jun;22(6):961-962. doi: 10.1007/s12094-020-02313-x.
6
Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer.西班牙病理学协会和西班牙医学肿瘤学会关于胰腺和胆道癌生物标志物测定的专家共识。
Clin Transl Oncol. 2022 Nov;24(11):2107-2119. doi: 10.1007/s12094-022-02873-0. Epub 2022 Aug 25.
7
Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.肿瘤液体活检：西班牙病理学会和西班牙肿瘤医学学会的共识声明。
Clin Transl Oncol. 2020 Jun;22(6):823-834. doi: 10.1007/s12094-019-02211-x. Epub 2019 Sep 26.
8
Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer.西班牙病理学学会和西班牙医学肿瘤学会关于胰腺和胆道癌生物标志物测定的专家共识
Rev Esp Patol. 2023 Jan-Mar;56(1):32-44. doi: 10.1016/j.patol.2022.06.004. Epub 2022 Aug 26.
9
[Recommendations for biomarker testing in epithelial ovarian cancer. A national consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology].[上皮性卵巢癌生物标志物检测的建议。西班牙病理学会和西班牙医学肿瘤学会的全国共识声明]
Rev Esp Patol. 2018 Apr-Jun;51(2):84-96. doi: 10.1016/j.patol.2017.11.002. Epub 2018 Jan 17.
10
Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).结直肠癌（CRC）生物标志物检测指南：西班牙病理学会（SEAP）和西班牙肿瘤内科学会（SEOM）的国家共识。
Clin Transl Oncol. 2012 Oct;14(10):726-39. doi: 10.1007/s12094-012-0856-5. Epub 2012 Jul 27.

本文引用的文献

1
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.《乳腺癌临床实践指南（NCCN 指南）》第 4 版 2017 年版
J Natl Compr Canc Netw. 2018 Mar;16(3):310-320. doi: 10.6004/jnccn.2018.0012.
2
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.降阶梯和升阶梯治疗早期乳腺癌：2017 年圣加仑国际早期乳腺癌专家共识会议关于早期乳腺癌的主要治疗。
Ann Oncol. 2017 Aug 1;28(8):1700-1712. doi: 10.1093/annonc/mdx308.
3
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.使用生物标志物指导早期浸润性乳腺癌女性辅助全身治疗决策：美国临床肿瘤学会临床实践指南重点更新
J Clin Oncol. 2017 Aug 20;35(24):2838-2847. doi: 10.1200/JCO.2017.74.0472. Epub 2017 Jul 10.

对《乳腺癌生物标志物：西班牙医学肿瘤学会和西班牙病理学会的共识声明》的勘误

Correction to: Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.

作者信息

Colomer R, Aranda-López I, Albanell J, García-Caballero T, Ciruelos E, López-García M Á, Cortés J, Rojo F, Martín M, Palacios-Calvo J

机构信息

Departamento de Oncología Médica, Hospital Universitario La Princesa, C/Diego de León, 62, 28006, Madrid, Spain.

Pathology Department, General University Hospital of Alicante, Alicante, Spain.

出版信息

Clin Transl Oncol. 2018 Aug;20(8):1093-1095. doi: 10.1007/s12094-018-1909-1.

DOI:10.1007/s12094-018-1909-1
PMID:29916189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6828516/
Abstract

On page 5 of the article, in the last paragraph of the section "Prognostic genetic platforms: molecular phenotypes and translation to the clinic" a relevant discrepancy between the text and Table 1 could be misunderstood, therefore the paragraph was corrected.

摘要

在文章第5页“预后基因平台：分子表型及向临床转化”部分的最后一段，文本与表1之间的一个相关差异可能会被误解，因此对该段落进行了修正。